STOCK Del(7Ndn-Magel2)#Mus/Orl

Status

Available to order

EMMA IDEM:16049
Citation informationRRID:IMSR_EM:16049 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameSTOCK Del(7Ndn-Magel2)#Mus/Orl
Alternative nameDel Ndn-Magel2
Strain typeTargeted Mutant Strains
Allele/Transgene symbolDel(7Ndn-Magel2)
Gene/Transgene symbolDel(7Ndn-Magel2)

Information from provider

ProviderFrançoise MUSCATELLI
Provider affiliationINSERMU1249, INMED
Genetic informationA 32 kb deletion that includes the mouse Necdin gene, the fragment between the mouse Necdin and Magel2 genes, the Magel2 promoter and half of Magel2 gene's coding region. A cre-loxP site-specific recombination strategy was used to mediate efficient in vivo trans-allelic recombination between a loxP site in the Necdin KO strain and a loxP site in the Magel2 KO strain, with a third mutant strain expressing Hprt1-cre recombinase. Three distinct strains were thus involved and their respective alleles were Ndntm1.1Mus (MGI:2653064), Magel2tm1.1Mus (MGI:4849506), Hprt1tm1(CAG-cre)Mnn (MGI:2181632). This approach could be used because both loxP sites are oriented in the same direction, while associated with either the Necdin KO allele or the Magel2 KO allele and located on a different chromosome 7. This allowed the creation of one new allele with deletion of the DNA region between the two loxP sites, including the Necdin gene and the 5’ coding region of Magel2 gene. An Hprt1-cre driver mouse strain was used, in which a strong CAG promoter is inserted into the X-linked Hprt1 locus, thus allowing a strong, constitutive expression of cre recombinase. See detailed decription in Barelle PY et al. JCI Insight, 2025, PMID:40048253.
Phenotypic informationHomozygous:
Similar to heterozygous mice with the Ndn-Magel2 deletion on the paternal allele. In general, the harmful phenotype is not a problem because: 1) it occurs in specific environmental conditions with a maximum lethality of 50%: it appears that in a clean animal facility (without pathogens) there is no lethality but when the health status is not so clean there is up to 50% of death of mutant mice; 2) more importantly, it only occurs when the mutation is transmitted via the paternal Ndn-Magel2 deletion allele. Since Necdin and Magel2 are exclusively expressed from the wild-type paternal alleles, the maternal alleles are always silenced (imprinted genes). So, as far as the silent maternal deletion allele is transmitted, the phenotype is normal. Maternal transmission is the way to maintain this mouse line, also to avoid genetic drift.

Heterozygous:
This is a pertinent model to study Prader-Willi syndrome (PWS). A subset of Del Ndn-Magel2 mice showed neonatal lethality. Behaviourally, surviving mutant mice exhibited sensory delays during infancy and alterations in social exploration at adulthood. Del Ndn-Magel2 mice had a lower body weight before weaning, persisting after weaning in males only, with reduced fat mass and improved glucose tolerance, and altered puberty. Adult mutant mice displayed increased ventilation and a persistent increase in apnea following a hypercapnic challenge. Transcriptomics analyses revealed a dysregulation of key circadian genes and alterations of genes associated with axonal function similar to PWS patients. At neuroanatomical levels, Del Ndn-Magel2 mice had an impaired maturation of oxytocin neurons and a disrupted development of melanocortin circuits.
Breeding historyC57BL/6J background strain, only. In crossing.
References
  • Investigation of a mouse model of Prader-Willi Syndrome with combined disruption of Necdin and Magel2.;Barelle Pierre-Yves, Sicardi Alicia, Schaller Fabienne, Buron Julie, Becquet Denis, Omnes Felix, Watrin Françoise, Alifrangis Marie-Sophie, Santos Catarina, Menuet Clément, François-Bellan Anne-Marie, Caron Emilie, Klucznik Jessica, Prevot Vincent, Bouret Sebastien G, Muscatelli Françoise, ;2025;JCI insight;10;; 40048253
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisednot known

Information from EMMA

Archiving centreCNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France
Animals used for archivingheterozygous C57BL/6J males

Literature references

  • Investigation of a mouse model of Prader-Willi Syndrome with combined disruption of Necdin and Magel2.;Barelle Pierre-Yves, Sicardi Alicia, Schaller Fabienne, Buron Julie, Becquet Denis, Omnes Felix, Watrin Françoise, Alifrangis Marie-Sophie, Santos Catarina, Menuet Clément, François-Bellan Anne-Marie, Caron Emilie, Klucznik Jessica, Prevot Vincent, Bouret Sebastien G, Muscatelli Françoise, ;2025;JCI insight;10;; 40048253

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).